Aims of SKION LATER Q2008-Psychosocial: 1. Survivors - to assess emotional functioning, generic and survivor-specific QoL, and executive functioning (< 18 years), and to compare with siblings and norm data; - to assess determinants of emotional…
ID
Source
Brief title
Condition
- Other condition
- Adjustment disorders (incl subtypes)
Synonym
Health condition
kwaliteit van leven
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
QoL(generic and survivor-specific), emotional functioning, anxiety, depression,
PTSS, psychosocial predictors, namely: 1) Survivors < 18jaar: - emotional
functioning (SDQ) - generic QoL (PEDSQL) - health status (EQ-5d-Y) -
developmental milestones (part of LVJV) - disease cognitions (part of CCSS) -
self-esteem (part of Kidscreen) - impact of cancer (BBSC) - anxiety (ZBV-K) -
PTSS (CRIES) 2) Survivors >= 18 jaar: - emotional functioning (GHQ-28) -
generic QoL (TAAQOL) - health status (EQ-5d-Y) - developmental milestones (part
of LVJV) - disease cognitions (ZCL) - self-esteem (Rosenberg Self-Esteem Scale)
- impact van kanker (IOC-YA) - anxiety and depression (HADS) - PTSS (SRS-PTSS)
3) Siblings < 18jaar: - emotional functioning (SDQ) - generic QoL (PEDSQL) -
health status (EQ-5d-Y) - self-esteem (part of Kidscreen) 4) Siblings >=
18jaar: - emotional functioning (GHQ-28) - generic QoL (TAAQOL) - health status
(EQ-5d) - self-esteem (Rosenberg Self-Esteem Scale) - anxiety and depression
(HADS) - PTSS (SRS-PTSS) 5) Parents: - emotional functioning (GHQ-28) - health
status (EQ-5d) - PTSS (SRS-PTSS) - cognitions about the child's disease (ZCL) -
parenting stress (NOSIK) - perceptions of child's disease (Child Vulnerability
Scale) - executive functioning child <18jaar (BRIEF) (For more details see
appendix)
Secondary outcome
n/a
Background summary
Survivors The diagnosis and treatment of childhood cancer is a dramatic event
that could influence physical and psychosocial functioning long time after
treatment has been terminated. The literature about the long-term psychosocial
consequences of childhood cancer yielded contradictory results. In many studies
overall mean adjustment has been found to be near normal levels. Most survivors
seem to cope well with the cancer experience and positive outcomes, for example
resiliency or posttraumatic growth, were found. The results of other studies,
on the other hand, suggested that survivors suffer more from depressive,
anxiety and posttraumatic stress symptoms than the general population.
Furthermore, a growing body of evidence suggests that more subtle or specific
areas may be adversely affected in long-term survivors. Studies of paediatric
psycho-oncological outcomes consistently identify a group of children and
family members (estimated 25-30%) who do not cope well with the cancer or who
have personal, family and social difficulties. Considering the previous,
research limited to psychopathology or generic HRQoL in survivors is
inadequate. It is of utmost importance to gain clear understanding of
survivor-specific Qol issues such as disease-related worries and positive
outcomes. In addition, research on psychosocial determinants of the
psychosocial consequences of childhood cancer is recommended strongly because
few clear medical risk factors for diminished psychosocial functioning have
been traced until now, with the exception of CNS-tumours, bone-tumours and
radiotherapy. Moreover, identification of psychosocial risk and protective
factors will enable care-providers to provide optimal support to patients and
survivors. Parents and siblings Childhood cancer exerts also considerable
strain on the parents and siblings. More research is needed to gain insight in
the long-term consequences of childhood cancer for parents and siblings.
Study objective
Aims of SKION LATER Q2008-Psychosocial: 1. Survivors - to assess emotional
functioning, generic and survivor-specific QoL, and executive functioning (< 18
years), and to compare with siblings and norm data; - to assess determinants of
emotional functioning, generic and survivor-specific QoL 2. Siblings - to
assess emotional functioning and generic QoL, and to compare with norm data; -
to assess determinants of emotional functioning and generic QoL. 3. Parents -
to assess emotional functioning, and to compare with norm data; - to assess
determinants of emotional functioning.
Study design
The study involves a cross-sectional study of a retrospective nationwide cohort
of 5-year survivors of childhood cancer (diagnosed 1960-2001) in the
Netherlands. We estimate that the total cohort will include 7000 survivors. For
SKION LATER Q2008-Psychosocial parents and siblings will also be approached.
Survivors, their parents and siblings will be asked to complete several
validated questionnaires concerning QoL(generic and survivor-specific),
emotional functioning (incl anxiety, depression, PTSS) and determinantis of QoL
and emotional functioning. (see appendix) Data of the survivors will be
compared with data of siblings and with norm data. Parental data will be
compared with norm data. Data of siblings will be compared with norm data.
Study burden and risks
The are no risks for the participants. The survivors will be invited for the
Q2008 SKION LATER study close to a visit to the LATER out patient clinic. The
burden depends on on the age of the survivor because this determines the number
of questionnaires to be completed for SKION LATER Q2008-Psychosociaal (see
appendix).
Heidelberglaan 25
Utrecht 3584CS
NL
Heidelberglaan 25
Utrecht 3584CS
NL
Listed location countries
Age
Inclusion criteria
All patients who were treated for childhood cancer (before age 18) in one of
the Pediatric Oncology Centers between 1960 and 2001 and who survived for at
least 5 years after diagnosis will be included in the SKION LATER study.
Participating centres are located in Amsterdam (VU University Medical Center
(VUMC)), Groningen (Children's Cancer Center/ University Medical Center
Groningen (UMCG)), Rotterdam (Rotterdam Erasmus MC-Sophia (REMC-S), Nijmegen
(University Medical Center Nijmegen (UMCN)), Leiden (Leiden University Medical
Center (LUMC) and Utrecht (Princess Máxima Center for Pediatric Oncology
(PMC)).
Exclusion criteria
diagnosis of childhood cancer with survival less than 5 years, age at diagnosis
>17 years or diagnosis while residing in foreign country; no ability to
read/write in Dutch
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL34985.018.10 |